An international group of researchers, led by Yoshihiro Kawaoka, a virologist from the University of Wisconsin-Madison, have looked at the pathophysiology of the 1918 influenza virus, and came up with intriguing results that might explain high mortality rates from that pandemic:
The study “proves the 1918 virus was indeed different from all of the other flu viruses we know of,” says Kawaoka, a professor in the UW-Madison School of Veterinary Medicine and at the University of Tokyo.
The new study, conducted at the Public Health Agency of Canada’s National Microbiology Laboratory in Winnipeg, Manitoba, utilized the 1918 flu virus, which has been reconstructed by researchers using genes obtained from the tissues of victims of the great pandemic in a reverse genetics process that enables scientists to make fully functioning viruses.
“In 1918, the existence of viruses had barely been recognized. In fact, the influenza virus wasn’t identified until 1933. Thanks to recent technological advancements, we are now able to study this virus and how it wreaked havoc around the globe,” explains Darwyn Kobasa, research scientist with the Public Health Agency of Canada and lead author of the new study. “This research provides an important piece in the puzzle of the 1918 virus, helping us to better understand influenza viruses and their potential to cause pandemics.”
By infecting monkeys with the virus, the team was able to show that the 1918 virus prompted a deadly respiratory infection that echoed historical accounts of how the disease claimed its victims.
Importantly, the new work shows that infection with the virus prompted an immune response that seems to derail the body’s typical reaction to viral infection and instead unleashes an attack by the immune system on the lungs. As immune cells attack the respiratory system, the lungs fill with fluid and victims, in essence, drown.
The mechanisms that contribute to the lethality of the virus were uncovered by University of Washington researchers using functional genomics, a technique in which researchers analyze the gene functions and interactions. Learning more about the virulence mechanisms of the 1918 flu virus may help researchers understand how to keep the virus from causing such a severe immune response.
“This study in macaques, combined with our earlier research showing the host response in mice infected with the 1918 flu, suggests that the host immune response is out of control in animals infected with the virus,” says Michael G. Katze, professor of microbiology at the University of Washington in Seattle, who led the functional genomics portion of the new study and led the previous mouse-based study. “Our analysis revealed potential mechanisms of virulence, which we hope will help us develop novel antiviral strategies to both outwit the virus and moderate the host immune response.”
The same excessive immune reaction is characteristic of the deadly complications of H5N1 avian influenza, the strain of bird flu present in Asia and which has claimed nearly 150 human lives, but has not yet shown a capacity to spread easily among people.
“What we see with the 1918 virus in infected monkeys is also what we see with H5N1 viruses,” Kawaoka says, suggesting that the ability to modulate immune response may be a shared feature of the most virulent influenza viruses.
In the new study, conducted in a high-level biosafety laboratory (BSL 4) at the Public Health Agency of Canada’s National Microbiology Laboratory, seven primates were infected with the reconstructed 1918 virus. Clinical signs of disease were apparent within 24 hours of infection, and within eight days, euthanization was necessary. The rapid course of the disease mirrors how quickly the disease ran its course in its human victims in 1918.
Upon infection, the virus grew rapidly in the infected animals, suggesting the agent somehow sets the stage for virulent infection. “Somehow, early in infection, this virus does something to the host that allows it to grow really well,” says Kawaoka. “But we don’t know what that is.”
Knowing that the virus does something early in infection to trigger such a devastating immune response may provide biomedical researchers with clues about how to intervene and stop or mitigate the virus’ potentially lethal effects, Kawaoka says.
Link…
Silver nanoparticle devices aren’t as revolutionary as they used to be, but the 
The number one cliche in covering medical technology is a reference to science fiction becoming science reality. Oooh…such clever word-play. But…in this case…it pretty much applies. This one comes to us by way of the Daily Mail. The National Geographic Channel is running a documentary on a Soviet Dr Demikhov and Dr White of the US, who did research in the 50s and 60s respectively on head transplants…
While the 
It seems that the market for non-invasive, non-suction, liposuction continues to pick up steam with the release of the UltraShape. This device is similar to the 
Given Imaging Ltd., maker of PillCam capsule endoscopes, will be taking its technology to a totally different plane. With the help of European consortium (members: Zarlink Semiconductor (Sweden and UK), Fraunhofer Institute for Biomedical Engineering, Israelitic Hospital and Indivumed (Germany), Imperial College of Science, Technology and Medicine (London, England), ITC-irst Research Institute (Italy), The Hebrew University of Jerusalem, Novamed and Ernst &Young of Israel), the company will be developing a capsule endoscopic system capable of molecular diagnostics to screen for GI cancers.
